Stock Price Movement and Market Context
On 16 Dec 2025, Chemfab Alkalis touched an intraday low of Rs.450, representing a fall of 3.11% from its previous close. This new low comes after two consecutive days of gains, signalling a reversal in short-term momentum. The stock also recorded an intraday high of Rs.474.45, up 2.15%, but ultimately closed lower, underperforming its commodity chemicals sector by 1.45% on the day.
Notably, Chemfab Alkalis is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a sustained downward trend. This contrasts with the broader market, where the Sensex, despite a negative opening and a fall of 345.75 points (-0.63%) to 84,679.86, remains close to its 52-week high of 86,159.02 and trades above its 50-day and 200-day moving averages.
Long-Term Price Performance
Over the past year, Chemfab Alkalis has experienced a substantial decline of 58.35%, a stark contrast to the Sensex’s positive return of 3.59% during the same period. The stock’s 52-week high was Rs.1,143.60, highlighting the extent of the price contraction. This underperformance is also evident when compared to the BSE500 index, which generated a modest return of 0.72% over the last year.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Financial Performance and Profitability Trends
Chemfab Alkalis’ recent quarterly results reveal a challenging financial environment. Net sales for the quarter stood at Rs.76.56 crores, reflecting a decline of 12.3% compared to the previous four-quarter average. Profit before tax excluding other income registered a loss of Rs.3.09 crores, a fall of 316.1% relative to the prior four-quarter average. Similarly, the net profit after tax was a loss of Rs.2.01 crores, down 274.8% from the average of the preceding four quarters.
These figures contribute to a broader trend of subdued growth, with operating profit showing an annual rate of decline of 6.47% over the last five years. The company’s return on capital employed (ROCE) stands at 1.8%, which, when combined with an enterprise value to capital employed ratio of 1.6, suggests a valuation that is relatively expensive compared to historical averages and peer companies within the commodity chemicals sector.
Valuation and Market Capitalisation
Despite its size, Chemfab Alkalis has a market capitalisation grade of 4, indicating a mid-tier market cap within its sector. The stock’s premium valuation relative to peers is notable, especially given the recent financial results and price performance. The company’s low average debt-to-equity ratio of 0.10 times reflects a conservative capital structure, which may provide some stability amid market volatility.
Shareholding and Market Participation
Domestic mutual funds hold a modest stake of 0.25% in Chemfab Alkalis. Given their capacity for detailed research and on-the-ground analysis, this relatively small holding may reflect a cautious stance towards the company’s current valuation and business outlook. This limited institutional participation contrasts with the broader market’s positive trajectory and may contribute to the stock’s subdued performance.
Comparative Market Performance
While the Sensex and BSE500 indices have maintained positive returns over the past year, Chemfab Alkalis has significantly underperformed. The stock’s negative return of 58.35% over this period is accompanied by a 75.8% decline in profits, underscoring the challenges faced by the company in maintaining growth and profitability in a competitive commodity chemicals sector.
Why settle for Chemfab Alkalis ? SwitchER evaluates this Commodity Chemicals micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Summary of Current Market Standing
Chemfab Alkalis’ stock price decline to Rs.450 marks a significant milestone in its recent trading history, reflecting a combination of weak quarterly results, valuation concerns, and limited institutional interest. The stock’s position below all major moving averages and its underperformance relative to sector and market benchmarks highlight ongoing challenges within the company’s financial and market environment.
While the company maintains a low debt-to-equity ratio, its profitability metrics and sales trends indicate pressures that have influenced investor sentiment and market valuation. The stock’s 52-week low contrasts sharply with its previous high of Rs.1,143.60, emphasising the scale of the price adjustment over the past year.
Market Environment and Sector Overview
The commodity chemicals sector, in which Chemfab Alkalis operates, has experienced mixed performance amid broader market fluctuations. The Sensex’s proximity to its 52-week high and its trading above key moving averages suggest a generally positive market environment, although individual stocks such as Chemfab Alkalis have diverged from this trend due to company-specific factors.
Conclusion
Chemfab Alkalis’ recent stock performance, culminating in a 52-week low of Rs.450, reflects a complex interplay of financial results, valuation metrics, and market dynamics. The company’s subdued sales and profit figures, combined with a premium valuation relative to peers, have contributed to its underperformance against broader market indices. The stock’s current trading below all major moving averages further underscores the challenges faced in regaining upward momentum.
Only for Rs. 14,999 - Get Access to 2 Years + 6 Months of All Premium Features on MarketsMojo. As low as ₹500/month! Claim 83% OFF →
